The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,951.00
Ask: 1,953.00
Change: -1.00 (-0.05%)
Spread: 2.00 (0.103%)
Open: 1,942.00
High: 1,958.00
Low: 1,938.00
Prev. Close: 1,959.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: Tandem FY sales down 17%; Hikma's opioid deal

Thu, 01st Feb 2024 20:00

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Hikma Pharmaceuticals PLC - London-based pharmaceutical company - Agrees US-wide settlement designed to resolve its opioid-related claims with US states, local communities and tribal nations. Agrees to pay up to USD115 million in cash and USD35 million in donations of naloxone, an opioid antagonist used to reverse the effects of opioid overdose. Stresses settlement is not an admission of wrongdoing or liability and will continue to defend against any litigation that this settlement does not resolve.

----------

Rockfire Resources PLC - London-based mineral exploration company - Further to announcement of December 12 2023, confirms receipt of USD2 million as part of its terminated acquisition of Emirates Gold DMCC and Emperesse Bullion LLC. These funds will be put towards multiple activities currently being undertaken. Further, says considering avenues and business development strategies to achieve a cash-positive business for investors. Continues to assess opportunities to attract partners to invest in its Queensland projects.

----------

Panther Metals PLC - Canada-focused mineral exploration company - Submits exploration permit application for additional drilling following the discovery of volcanogenic massive sulphide base metal mineralisation on the Wishbone prospect at the Obonga project in northern Ontario. Explains the submitted application covers a planned series of up to 39 diamond core drill holes and associated down-hole geophysics surveys spread across the Wishbone prospect. "With all plans firmly in place we would expect to commence drilling within a relatively short period of time post the granting of the permit," company says.

----------

GCP Asset Backed Income Fund Ltd - London-based investor, which backs medium to long-term fixed or floating rate loans secured against physical assets or cash flows - Receives cash proceeds of GBP18 million from the early partial repayment of a loan secured against a portfolio of property investments. The contractual repayment date of the loan is March 2024. As part of deal, agrees with the relevant borrower in connection with the prepayment, to extend the maturity of the remaining amount of the loan and other loans made to the wider borrower group totalling GBP53.7 million, which are also due in March, to no later than June 29. Also agrees to an increase in the interest rates of the group loan to align with the current credit market conditions. Following the prepayment, estimates cash balance of around GBP50 million. Says has no outstanding balance under its revolving credit facility. Continues to discuss potential GBP7 million share buyback programme with advisers.

----------

Tandem Group PLC - Birmingham, England-based sports and leisure product retailer - Trading update to December 31. Expects annual revenue of GBP22.2 million, down 17% from the prior year, and in line with updated guidance provided in December. Expects annual pretax loss to be in line with guidance. Explains the economic environment in the consumer sector continues to pose challenges and suppressed consumer spending continues to impact the domestic sales market, which proved more challenging than anticipated. Targets 19% increase in 2024 sales to GBP26.5 million and a return to profitability. Annual results will be released on March 25.

----------

First Class Metals PLC - Ontario, Canada-focused exploration company - Announces high-grade gold assays from channel sampling undertaken following the recently completed exploration at the 100% owned Sunbeam property. Describes results as very encouraging and typify this style of mineralisation. Says high grade gold assays reported of up to 18.8 grammes per tonne gold.

----------

Neo Energy Metals PLC - South Africa-focused uranium developer - Reports pretax loss for 18 months to September 30, 2023 of GBP900,000 compared to loss of GBP602,000 for the year ended March 2022. No revenue. Administrative expenses more than doubled to GBP936,000 from GBP457,000 in the shortened trading period. Basic and diluted loss per share was 0.62p compared to LPS of 0.41p.

----------

Emmerson PLC - Morocco-focused potash development company - Announce results of an in-depth scoping study at its Khemisset potash project. Says this substantially improves the Project's economics, with annual earnings before interest, tax, depreciation and amortisation seen at USD440 million per annum compared to original USD258 million. Total project capex now estimated to be USD525 million compared to the original USD539 million. Estimates all-in sustaining cost of USD163 per tonne, at the "lower end of the cost curve" and delivers robust returns across a range of potash price assumptions.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
20 Oct 2021 09:51

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

Read more
27 Sep 2021 12:14

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.